Paolo Fiorina

Paolo Fiorina

Harvard University

H-index: 62

North America-United States

About Paolo Fiorina

Paolo Fiorina, With an exceptional h-index of 62 and a recent h-index of 36 (since 2020), a distinguished researcher at Harvard University, specializes in the field of MEDICINE-DIABETES.

His recent articles reflect a diverse array of research interests and contributions to the field:

Methods and compositions for treating multiple sclerosis

Treatment of type 1 diabetes and autoimmune diseases or disorders

TMEM219 regulates the transcription factor expression and proliferation of beta cells

Hyperglycemia impairs EAAT2 glutamate transporter trafficking and glutamate clearance in islets of Langerhans: implications for type 2 diabetes pathogenesis

P171 Rescuing Intestinal Stem Cells via TMEM219 inhibition promotes mucosal healing in Crohn’s disease

A multi-omics integration approach relying on circulating factors does not discern endotypes in childhood type 1 diabetes.

Early lung diffusion abnormalities and airways’ inflammation in children with type 1 diabetes

Type 2 diabetes mellitus pharmacological remission with dapagliflozin plus oral semaglutide

Paolo Fiorina Information

University

Position

Università degli Studi di Milano-Boston Children's Hospital-Harvard Medical School

Citations(all)

13744

Citations(since 2020)

7126

Cited By

8208

hIndex(all)

62

hIndex(since 2020)

36

i10Index(all)

173

i10Index(since 2020)

119

Email

University Profile Page

Harvard University

Google Scholar

View Google Scholar Profile

Paolo Fiorina Skills & Research Interests

MEDICINE-DIABETES

Top articles of Paolo Fiorina

Title

Journal

Author(s)

Publication Date

Methods and compositions for treating multiple sclerosis

2020/7/7

Treatment of type 1 diabetes and autoimmune diseases or disorders

2024/1/23

TMEM219 regulates the transcription factor expression and proliferation of beta cells

Frontiers in Endocrinology

Francesca D’Addio

Emma Assi

Anna Maestroni

Giada Rossi

Vera Usuelli

...

2024/1/22

Hyperglycemia impairs EAAT2 glutamate transporter trafficking and glutamate clearance in islets of Langerhans: implications for type 2 diabetes pathogenesis

American Journal of Physiology-Endocrinology and Metabolism

Alessandra Galli

Stefania Moretti

Nevia Dule

Eliana Sara Di Cairano

Michela Castagna

...

2024/5/1

P171 Rescuing Intestinal Stem Cells via TMEM219 inhibition promotes mucosal healing in Crohn’s disease

Journal of Crohn's and Colitis

F D'Addio

F Canducci

V Marin

E Assi

A Maestroni

...

2024/1/1

A multi-omics integration approach relying on circulating factors does not discern endotypes in childhood type 1 diabetes.

Alessandra Petrelli

Valentina Codazzi

Nicola Baldoni

Giulia Scotti

Anna Giovenzana

...

2024/4/18

Early lung diffusion abnormalities and airways’ inflammation in children with type 1 diabetes

Acta Diabetologica

Pierachille Santus

Marina Saad

Elisa Giani

Maurizio Rizzi

Chiara Mameli

...

2024/3

Type 2 diabetes mellitus pharmacological remission with dapagliflozin plus oral semaglutide

Pharmacological Research

Maria Elena Lunati

Vincenzo Cimino

Davide Bernasconi

Alessandra Gandolfi

Paola Silvia Morpurgo

...

2024/1/1

Daytime hypoglycemic episodes during the use of an advanced hybrid closed loop system

Diabetes Research and Clinical Practice

Antonio Rossi

Laura Montefusco

Elia Reseghetti

Ida Fabrizia Pastore

Giada Rossi

...

2023/12/1

Targeting a novel apoptotic pathway in human disease

Francesca D'Addio

Laura Montefusco

Maria Elena Lunati

Ida Pastore

Emma Assi

...

2023/6

Igfbp3 antibodies and therapeutic uses thereof

2023/2/9

Long-term activity and safety of a low-dose hydrocortisone tear substitute in patients with dry eye disease

Current Eye Research

Maurizio Rolando

Elena Villella

Lara Loreggian

Sara Marini

Cristian Loretelli

...

2023/9/2

The anti-inflammatory and immunological properties of SGLT-2 inhibitors

Giulia Bendotti

Laura Montefusco

Maria Elena Lunati

Vera Usuelli

Ida Pastore

...

2022/8/1

Real world effectiveness of subcutaneous semaglutide in type 2 diabetes: A retrospective, cohort study (Sema-MiDiab01)

Frontiers in Endocrinology

Cesare C Berra

Maria Chiara Rossi

Marco Mirani

Daniela Ceccarelli Ceccarelli

Cristina Romano

...

2023/1/18

Very-low-calorie-ketogenic-diet (VLCKD) as a nutritional therapeutical option for chronic management in obese patients with type 2 diabetes: a case report

Endocrine Abstracts

Chiara Parazzoli

Graziella Volpi

Paola S Morpurgo

Alessandra Gandolfi

Bolla Andrea Mario

...

2023/5/2

AWARE A novel web application to rapidly assess cardiovascular risk in type 2 diabetes mellitus

Acta Diabetologica

Cesare Berra

Roberto Manfrini

Marco Mirani

Loredana Bucciarelli

Ahmed S Zakaria

...

2023/9

Mechanisms of action of incretin receptor based dual-and tri-agonists in pancreatic islets

Franco Folli

Giovanna Finzi

Roberto Manfrini

Alessandra Galli

Francesca Casiraghi

...

2023/11/1

Increased Risk of Diabetes and Diabetic Ketoacidosis Associated With COVID-19.

Diabetes

Laura Montefusco

Ida Pastore

Maria Elena Lunati

Paolo Fiorina

2023/5/1

Cells with increased immuno-regulatory properties and methods for their use and manufacture

2023/1/5

Tmem219 antibodies and therapeutic uses thereof

2023/8/3

See List of Professors in Paolo Fiorina University(Harvard University)

Co-Authors

H-index: 119
Mohamed H. Sayegh

Mohamed H. Sayegh

American University of Beirut

H-index: 113
Camillo Ricordi

Camillo Ricordi

University of Miami

H-index: 75
Franco Folli

Franco Folli

Università degli Studi di Milano

H-index: 71
Clive Wasserfall, PhD

Clive Wasserfall, PhD

University of Florida

H-index: 65
Antonello Pileggi

Antonello Pileggi

University of Miami

H-index: 64
Alessandro Doria

Alessandro Doria

Harvard University

academic-engine